Preliminary results of a phase I, first-in-human, dose escalation study of IMM2902 in patients with HER2-expressing advanced solid tumors - Zhang, Jian; Zhao, Chuanhua; Cheng, Ying; Zhu, Liming; Song, Zhengbo; Xu, Nong; Wang, Zhen; Wang, Yanping; Du, Yiqun; Jing, Deqiang; Chen, Dinglu; Qu, Qiaofeng; et al. (Journal of clinical oncology, 2023)